Quest for the right Drug
הקסוויקס 85 מ"ג HEXVIX 85 MG (HEXAMINOLEVULINATE AS HYDROCHLORIDE, HEXYL AMINOLEVULINATE AS HYDROCHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
לתוך שלפוחית : INTRAVESICAL
צורת מינון:
אין פרטים : POWDER AND SOLVENT FOR INTRAVESICAL SOLUTION
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Pharmaceutical particulars : מידע רוקחי
6. Pharmaceutical particulars 6.1 List of excipients Powder: None Solvent: Water for injections, Sodium chloride, Disodium phosphate dihydrate, Potassium dihydrogen phosphate, Hydrochloric acid 1 M, Sodium hydroxide. 6.2 Incompatibilities This medicinal product must not be mixed with other medicinal products. 6.3 Shelf life The expiry date of the product is indicated on the packaging materials From a microbiological point of view, the reconstituted product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at 2°C - 8°C. 6.4 Special precautions for storage Do not store above 30°C. For storage conditions after reconstitution of the medicinal product, see section 6.3. 6.5 Nature and contents of container Pack of one 10 ml Type I colourless glass vial with butyl rubber stopper containing powder, and one 50 ml cyclic olefin copolymer syringe with plunger stopper (bromobutyl rubber) and plunger rod, containing solvent. The pack contains 1 vial with powder and 1 prefilled syringe with solvent. 6.6 Special precautions for disposal and other handling No special requirements for disposal. Hexaminolevulinate may cause sensitisation by skin contact. Handling instructions for the pharmacist or other healthcare professionals: All steps should be performed with sterile equipment and under aseptic conditions. A brief description of the reconstitution procedure is provided below. 1. Fasten the plunger rod into the rubber stopper of the syringe by turning the plunger rod clockwise until it stops. 2. Remove the cap from the syringe and keep it for later use. Connect a needle suitable for reconstitution to the syringe. Hold the syringe upright and carefully press the plunger rod upward to remove air. 3. Using the prefilled syringe, inject about 10 ml of the solvent into the vial of Hexvix powder. The vial should be about ¾ full. 4. Without withdrawing the needle from the vial, hold the powder vial and the syringe in a firm grip and shake gently to ensure complete dissolution. 5. Withdraw all of the dissolved solution from the powder vial into the syringe. 6. Disconnect the empty vial from the syringe and discard it. Disconnect the needle from the syringe tip and discard it. Plug the syringe with the syringe cap. Gently mix the contents of the syringe. Hexvix is now reconstituted and ready for use. The appearance of the reconstituted solution is clear to slightly opalescent, and colourless to pale yellow. Add two hours to the present time and write the resulting expiration time and date on the syringe label. The product is for single use only. Any unused product should be discarded.
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לרופא
11.01.23 - עלון לרופאעלון מידע לצרכן
11.01.23 - החמרה לעלוןלתרופה במאגר משרד הבריאות
הקסוויקס 85 מ"ג